Pazopanib in the management of advanced soft tissue sarcomas

Therapy of soft tissue sarcomas represents an area of significant unmet need in oncology. Angiogenesis has been explored as a potential target both preclinically and clinically, with suggestions of activity. Pazopanib is a multitargeted tyrosine kinase inhibitor with prominent antiangiogenic effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Cranmer, Lee D, Loggers, Elizabeth T, Pollack, Seth M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907704/
https://www.ncbi.nlm.nih.gov/pubmed/27354810
http://dx.doi.org/10.2147/TCRM.S84792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907704/
https://www.ncbi.nlm.nih.gov/pubmed/27354810
http://dx.doi.org/10.2147/TCRM.S84792

Ejemplares similares